Financial Health Check: Examining Supernus Pharmaceuticals Inc (SUPN)’s Key Ratios

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

Supernus Pharmaceuticals Inc (NASDAQ: SUPN) closed the day trading at $28.97 down -2.39% from the previous closing price of $29.68. In other words, the price has decreased by -$2.39 from its previous closing price. On the day, 0.56 million shares were traded. SUPN stock price reached its highest trading level at $30.18 during the session, while it also had its lowest trading level at $28.86.


For a better understanding of SUPN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.95. For the most recent quarter (mrq), Quick Ratio is recorded 1.49 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.

Jefferies Upgraded its Hold to Buy on April 13, 2021, whereas the target price for the stock was revised from $25 to $40.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 ’24 when Bhatt Padmanabh P. sold 14,491 shares for $35.31 per share. The transaction valued at 511,677 led to the insider holds 8,570 shares of the business.

Bhatt Padmanabh P. sold 400 shares of SUPN for $14,124 on Mar 20 ’24. The Sr. VP of IP, CSO now owns 8,570 shares after completing the transaction at $35.31 per share. On Mar 19 ’24, another insider, Bhatt Padmanabh P., who serves as the Sr. VP of IP, CSO of the company, sold 12,364 shares for $35.31 each. As a result, the insider received 436,573 and left with 8,570 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SUPN now has a Market Capitalization of 1631636736 and an Enterprise Value of 1336995200. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.67 while its Price-to-Book (P/B) ratio in mrq is 1.71. Its current Enterprise Value per Revenue stands at 2.238 whereas that against EBITDA is 14.752.

Stock Price History:

Over the past 52 weeks, SUPN has reached a high of $35.96, while it has fallen to a 52-week low of $21.99. The 50-Day Moving Average of the stock is -8.40%, while the 200-Day Moving Average is calculated to be -0.39%.

Shares Statistics:

Over the past 3-months, SUPN traded about 433.55K shares per day on average, while over the past 10 days, SUPN traded about 543940 shares per day. A total of 54.72M shares are outstanding, with a floating share count of 52.62M. Insiders hold about 4.28% of the company’s shares, while institutions hold 107.09% stake in the company. Shares short for SUPN as of 1714435200 were 4820516 with a Short Ratio of 11.12, compared to 1711584000 on 4822753. Therefore, it implies a Short% of Shares Outstanding of 4820516 and a Short% of Float of 13.370000000000001.

Most Popular

[the_ad id="945"]